NRIP1 (Nuclear Receptor Interacting Protein 1)

A key transcriptional coregulator in nuclear receptor signaling, metabolism, and cancer.

Gene Information Card

Symbol NRIP1
Full Name Nuclear Receptor Interacting Protein 1
Gene Type Protein coding
Chromosomal Location 21q11.2
NCBI Gene ID 8204 ncbi.nlm.nih.gov/gene/8204
Ensembl ID ENSG00000142168
UniProt ID P48552
OMIM ID 602490
HGNC ID 8001
Aliases RIP140

Description

NRIP1 (nuclear receptor interacting protein 1), also known as RIP140, is a transcriptional coregulator that modulates the activity of nuclear receptors such as estrogen receptor (ER), androgen receptor (AR), and peroxisome proliferator-activated receptors (PPARs). It functions primarily as a repressor of nuclear receptor-mediated transcription by recruiting histone deacetylases and other chromatin-modifying complexes. NRIP1 plays critical roles in energy metabolism, adipogenesis, reproduction, and cancer progression. The gene is located on chromosome 21q11.2 and encodes a 1158-amino acid protein.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast Cancer NRIP1 overexpression enhances ER signaling and promotes tamoxifen resistance; acts as a coactivator in certain contexts. ClinVar, COSMIC, PMID: 19124656
Endometrial Cancer NRIP1 amplification and overexpression correlate with poor prognosis and hormone-independent growth. COSMIC, PMID: 21804562
Obesity and Metabolic Syndrome NRIP1 knockout mice show increased energy expenditure and resistance to diet-induced obesity; human variants linked to metabolic traits. OMIM, PMID: 16858410
Prostate Cancer NRIP1 modulates AR activity and is associated with castration-resistant prostate cancer. COSMIC, PMID: 22926525

Expression Profile

Tissue Expression
Tissue nTPM level
Adipose tissue 12.5 Medium
Breast 8.3 Low
Endometrium 15.2 Medium
Liver 6.1 Low
Skeletal muscle 4.7 Low
Ovary 10.8 Medium
Cell Line Expression
Cell Line nTPM Notes
MCF7 (breast cancer) 18.4 ER-positive; high NRIP1 expression
HepG2 (liver cancer) 7.2 Moderate expression
HeLa (cervical cancer) 5.9 Low expression
LNCaP (prostate cancer) 14.1 AR-positive; moderate-high expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1234C>T (p.Arg412*) Nonsense Rare Loss of function; truncation of C-terminal repression domain
c.567_568insA (p.Glu190Argfs*12) Frameshift Rare Loss of function; premature stop
c.2101G>A (p.Gly701Arg) Missense 0.01% (gnomAD) Unknown functional effect; located in ligand-binding domain
c.2980C>T (p.Arg994Trp) Missense 0.005% Potential gain of function; altered cofactor interaction
Mutation functional classification

Loss of Function (LOF)

Truncating mutations (nonsense, frameshift) that remove the C-terminal repression domain or disrupt nuclear receptor binding lead to loss of repressive activity, observed in rare metabolic disorders.

Gain of Function (GOF)

Missense mutations in the ligand-binding domain (e.g., p.Arg994Trp) may enhance coactivator recruitment, contributing to hormone-independent cancer growth.

Dominant Negative (DN)

No well-characterized dominant-negative mutations reported; however, truncated isoforms could interfere with wild-type NRIP1 function.

Pathways

Nuclear receptor signaling (R-HSA-383280)
PPAR signaling pathway (KEGG hsa03320)
Estrogen signaling pathway (KEGG hsa04915)
Adipogenesis (R-HSA-381340)

Protein Summary

NRIP1 (RIP140) is a 1158-amino acid nuclear protein that acts as a ligand-dependent coregulator for multiple nuclear receptors. It contains an N-terminal repression domain, a central nuclear receptor interaction domain with LXXLL motifs, and a C-terminal repression domain. NRIP1 recruits histone deacetylases (HDACs) and C-terminal binding protein (CtBP) to repress transcription, but can also activate transcription in certain cellular contexts. The protein is highly expressed in metabolic tissues (adipose, muscle) and hormone-responsive cancers. Post-translational modifications include phosphorylation and acetylation, which modulate its activity and stability.

Related Products

Product name Cat.No. Species Gene ID
NRIP1 Knockout HEK293 Cell Line EDJ-KQ2537 Human 8204 Details Get a Quote
CNRIP1 Knockout HEK293 Cell Line EDJ-KQ8311 Human 25927 Details Get a Quote
NRIP1 Knockout A-549 Cell Line EDJ-KQ24556 Human 8204 Details Get a Quote
NRIP1 Knockout HCT 116 Cell Line EDJ-KQ24557 Human 8204 Details Get a Quote
NRIP1 Knockout HeLa Cell Line EDJ-KQ24558 Human 8204 Details Get a Quote
CNRIP1 Knockout HeLa Cell Line EDJ-KQ34283 Human 25927 Details Get a Quote
CNRIP1 Knockout A-549 Cell Line EDJ-KQ64341 Human 25927 Details Get a Quote
CNRIP1 Knockout HCT 116 Cell Line EDJ-KQ72794 Human 25927 Details Get a Quote
Displaying Records 1 To 8 Of 8 Records
Contact Us
*
*
*
*
How did you hear about us: